The Office of Fair Trading (OFT) has dropped the requirement that veterinary practices display a poster in waiting rooms which tells clients what the top ten medicines they supply are, and their costs.
The requirement was apparently dropped, initially for a six month period, following pressure from the Royal College, which felt says it felt the poster did not entirely serve its purpose.
The requirement for the poster was brought in following the Competition Commission investigation into veterinary medicine sales in 2005, as part of a range of measures. Some of the responsibilities were enforced via the RCVS as an alternative to legislation under the Fair Trading Act, to ensure that clients have access to sufficient information to be able to decide where to obtain veterinary prescriptions and medicines.
The poster, which was outlined in the Guide to Professional Conduct, and subsequently the Code of Professional Conduct, had to include information about prescriptions and repeat prescriptions, together with the 'ten relevant veterinary medicinal products most commonly prescribed during a recent and typical three-month period'.
How 'most commonly prescribed' has been calculated has often varied - for example, by price, volume, number of prescriptions, etc - and, in addition, different formulations, brands or pack sizes of the same active ingredient could cause confusion.
RCVS President, Jacqui Molyneux said: "Having seen how this has worked in practice, we have been keen to push for change because it was felt that the list could be confusing to clients.
"We have also been mindful of the fact that the ways in which consumers access information has changed radically over the last seven years or so, with internet searches becoming more prevalent.
"These factors conspired to make the list less meaningful as a tool that allowed consumers to shop around. It is thus hoped that the removal of the list will reduce potential misunderstanding among the public."
During the first six months following the change, the College and the OFT will monitor the situation. If there is no appreciable level of complaint from the public, the change will become permanent.
The other requirements of supporting guidance to the Code of Professional Conduct Chapter 10 (Fair Trading Requirements) remain unchanged (www.rcvs.org.uk/fairtrading), and the OFT recommends that the notice advising clients that they can obtain a prescription from the practice be made even more prominent.
In addition, it remains important that veterinary surgeons communicate medicines prices clearly to their clients and other callers, and that invoices itemise individual products supplied (www.rcvs.org.uk/medicines).
The Office of Fair Trading has concluded that it has no grounds to take action against IDEXX Laboratories Limited following an investigation into alleged abuses of a dominant position in the veterinary diagnostic testing sector.
The OFT opened its investigation in November 2010 after it received a complaint alleging that IDEXX was abusing a dominant position in the market for the supply of in-clinic pet testing equipment in order to foreclose competition.
The conduct assessed by the OFT included alleged practices of:
The full reasoning for the OFT's conclusion, including details of the methodologies used by the OFT to assess potential theories of harm relating to alleged mixed bundling (also known as multi-product rebates) and alleged predatory pricing in systems markets, is available from the OFT's website, here.